Skip to main content

Table 2 Multivariate relationship between study parameters and PD1 and PDL1 positivity in tumoral and background cells

From: Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma

Variable p Exp(B) 95% C.I.for EXP(B)
Lower Upper
Gender PD1 positivity in tumor cell 0.999  < 0.001  < 0.001 -
PDL1 positivity in tumor cells 0.999  < 0.001  < 0.001 -
PD1 positivity in background cells 0.999  < 0.001  < 0.001 -
PDL1 positivity in background cells 0.505 0.028  < 0.001 1045.587
Age PD1 positivity in tumor cell 0.503 0.953 0.829 1.096
PDL1 positivity in tumor cells 0.389 1.050 0.939 1.174
PD1 positivity in background cells 0.996 0.011  < 0.001 -
PDL1 positivity in background cells 0.605 0.885 0.556 1.408
Size PD1 positivity in tumor cell 0.389 0.421 0.059 3.017
PDL1 positivity in tumor cells 0.658 0.514 0.027 9.830
PD1 positivity in background cells 0.966 1.873E + 41  < 0.001 -
PDL1 positivity in background cells 0.467  < 0.001  < 0.001 3.481E + 15
Aggressive tumor PD1 positivity in tumor cell 0.999  < 0.001  < 0.001 -
PDL1 positivity in tumor cells 0.999 289,378,866.6  < 0.001 -
PD1 positivity in background cells 0.999 633,488,326.857  < 0.001 -
PDL1 positivity in background cells 0.488 379.467  < 0.001 7,470,964,009